Номер части:
Журнал
ISSN: 2411-6467 (Print)
ISSN: 2413-9335 (Online)
Статьи, опубликованные в журнале, представляется читателям на условиях свободной лицензии CC BY-ND

STUDY OF THE POSSIBILITIES OF PREOPERATIVE CHEMOTHERAPY IN MULTIPLE METASTASIS OF COLORECTAL CANCER IN THE LIVER (8-11)



Науки и перечень статей вошедших в журнал:
DOI:
Дата публикации статьи в журнале: 2020/09/09
Название журнала: Евразийский Союз Ученых, Выпуск: 77, Том: 1, Страницы в выпуске: 8-11
Автор: Islamov Kh.D.
, Republican Scientific and Practical Medical Center of Oncology and Radiology of the Ministry of Health of the Republic of Uzbekistan (RSSPMC OR MOH RUz),
Автор: Niyozova Sh.Kh.
, Tashkent medical academy ,
Автор:
, ,
Анотация: Preoperative chemotherapy (CT) in 35 patients with colorectal cancer (CRC) with liver metastases demonstrated a high frequency of objective effects - in 22 (62.9%) patients, stabilization was noted in 10 (28.6%) cases. With bilobar liver metastases and the use of oxaliplatin-containing regimens, partial regression was 62.9%. Side effects in most cases were clinically insignificant, no deaths were observed. The results obtained demonstrate the possibility of performing extended surgical operations in the majority of CRC patients with multiple liver metastases after preoperative CT.
Ключевые слова: colorectal cancer   liver metastases   preoperative chemotherapy                        
Данные для цитирования: Islamov Kh.D. Niyozova Sh.Kh. . STUDY OF THE POSSIBILITIES OF PREOPERATIVE CHEMOTHERAPY IN MULTIPLE METASTASIS OF COLORECTAL CANCER IN THE LIVER (8-11) // Евразийский Союз Ученых. Медицинские науки. 2020/09/09; 77(1):8-11.

Список литературы: 1.Assessorova Yu.Yu., Kireev G.V., Balenkov O.Yu. The most important modern trends in cancer incidence in different countries (review) // Journal of Theoretical and Clinical Medicine. -2009. -№2. –P.7781. 2.Balachandran V.P., Arora A., Gönen M. et al. A validated prognostic multigene expression assay for overall survival in resected colorectal cancer liver metastases // Clin. Cancer. Res. -2016. –V.22. –P.25752582. 3.Balenkov O.Yu., Yuldasheva D.Yu., Kireev G.V., Kamishov S.V. Study of oncological morbidity in the population of Tashkent // Journal of Theoretical and Clinical Medicine. -2007. -№ 3. –P.90-92. 4.Bazin I.S., Mamontov K.G. Modern approaches to chemotherapy in the complex treatment of localized colon cancer // Oncological Coloproctology. -2011. №2. -P.27-36. 5. Feo L., Polcino M., Nash G.M. Resection of the Primary Tumor in Stage IV Colorectal Cancer: When Is It Necessary? // Surg. Clin. North. Am. -2017. –V.97. –P.657-669. 6.Jones R.P., Brudvik K.W., Franklin J.M., Poston G.J. Precision surgery for colorectal liver metastases: Opportunities and challenges of omics-based decision making // Eur. J. Surg. Oncol. -2017. –V.43. –P.875– 883. 7.Kamishov S.V. Mechanisms of immune disorders in patients with ovarian cancer receiving chemotherapy and their dynamics during immunotherapy // Eurasian Oncological Journal, -2018 -P. 563-576 8.Kamishov S.V. Modern immunopharmacotherapy in the complex treatment of cervical cancer // Bulletin of Science and Education - 2018 -V.2 (6 (42)), -P. 57-61 9.Kamishov S.V., Pulatov D.A., Nishanov D.A., Yuldasheva N.Sh. Influence of the expression level of tumor markers on the results of treatment of patients with cervical cancer who received concomitant immunotherapy // Eurasian Oncological Journal 5 (1), - 2017-P. 68-76 10.Kamishov S.V., Pulatov D.A., Yusupova N.B., Niezova Sh.Kh. The state of immunoreactivity of patients with cervical cancer against the background of extracorporeal immunopharmacotherapy // Bulletin of the National. medical surgeon. center them. N.I. Pirogov 13 (1), -P. 98-102 11. Kamishov S.V., Pulatov D.A.Supportive immunotherapy in complex treatment of patients with oncogynaecological diseases //The scientific heritage - 2017 -V.18 (18), 23-27 12. Kamyshov S.V., Nishanov D.A., Pulatov D.A., Yuldasheva N.S. //Izuchenie markerov apoptoza, proliferacii i angiogeneza u bol'nyh rakom jaichnika, poluchivshih soprovoditel'nuju immunoterapiju [The study of markers of apoptosis, proliferation and angiogenesis in patients with ovarian cancer who received accompanying immunotherapy]. Zlokachestvennye opuholi [Malignant tumors], 1, 84-91 13. Kamyshov S.V., Pulatov D.A., Nishanov D.A., Yuldasheva N.S., Yusupova N.B. Znachimost'ocenki molekuljarno-biologicheskih onkomarkerov v soprovoditel'noj immunoterapii pri rake shejki matki [Significance of the assessment of molecular biological tumor markers in accompanying immunotherapy for cervical cancer]. Onkologija i radiologija Kazahstana [Oncology and radiology of Kazakhstan], 2017 V.2 -P. 45-48 14. Kamyshov S.V., Pulatov D.A., Yuldasheva N.S. Ispol'zovanie metodov gravitacionnoj hirurgii krovi v kompleksnom lechenii bol'nyh rakom jaichnika [The use of gravitational blood surgery methods in the complex treatment of patients with ovarian cancer]. Vestnik Nacional'nogo mediko-hirurgicheskogo centra im. NI Pirogova BBBulletin of the National Medical and Surgical Center after Ni Pirogov], -201712 (1), -P. 52-56Nigri G., Petrucciani N., Ferla F. et al. Neoadjuvant chemotherapy for resectable colorectal liver metastases: what is the evidence? Results of a systematic review of comparative studies // Surgeon. 2015. –V.13. –P.83-90. 15.Nordlinger B., Sorbye H., Glimelius B. et al. EORTC liver metastases intergroup randomized phase III study 40983: long-term survival results // J. Clin. Oncol. -2012. -V.30 (Sup.). -Abs.3508. 16. Oxenberg J., Papenfuss W., Esemuede I. et al. Multidisciplinary cancer conferences for gastrointestinal malignancies result in measureable treatment changes: a prospective study of 149 consecutive patients // Ann. Surg. Oncol. -2015. –V.22. –P.1533-1539. 17. Pulatov D.A., Ibragimov Zh.M., Kamishov S.V. Comparative assessment of the toxicity of treatment of patients with chemoresistant colorectal cancer // Oncology and Radiology of Kazakhstan -2018 V.44 (2), -P. 58-61 18. Roberts K.J., White A., Cockbain A. et al. Performance of prognostic scores in predicting long- term outcome following resection of colorectal liver metastases // Br. J. Surg. -2014. –V.101. –P.856-866. 19. Sekacheva M.I., Polishchuk L.O., Bagmet N.N., Skipenko O.G. Results of surgical treatment of metastatic colorectal cancer after drug therapy with the addition of bevacizumab // Modern Oncology. -2012. – V.14. -№2. -P.38-41. 20. Tillyashaikhov M.N., Kamishov S.V. Features of the cellular status of immunity in patients with cervical cancer European science, 2018 No. 5 (37) P.75-79. 21. Tillyashaikhov M.N., Kamishov S.V. Features of the humoral status of immunity in patients with cervical cancer // Materials of the conference International scientific review of the problems and prospects of modern science and education 2018 -p. 84- 87 22. Vozdvizhensky M.O., Dudko S.M. Modern approaches to resection of liver metastases in colorectal cancer // Vestnik Ross. military med. academy. -2012. -№ 1. -V.37. –P.291-295.


Записи созданы 442

Похожие записи

Начните вводить, то что вы ищите выше и нажмите кнопку Enter для поиска. Нажмите кнопку ESC для отмены.

Вернуться наверх